The combination therapy of continuous intravenous infusion of 5-FU and sorafenib

2 trials

Sponsors

Hokkaido University Hospital

Conditions

Hepatocellular carcinoma

Phase 1

A phase 1 study of 5-FU and sorafenib combination therapy in patients with hepatocellular carcinoma. Non-blind dosage gradual increase study

Active, not recruitingJPRN-UMIN000004313

Hokkaido University HospitalHepatocellular carcinoma

Start: 2010-09-01Target: 18Updated: 2026-06-29

Phase 2

A phase II clinical study of 5-FU and sorafenib combination therapy in patients with hepatocellular carcinoma. Uncontrolled exploratory clinical study

RecruitingJPRN-UMIN000009026

Hokkaido University HospitalHepatocellular carcinoma

Start: 2012-09-18Target: 98Updated: 2026-06-29